Udai S. Kammula

University of Pittsburgh — United States

Immunology and Microbiology · Life Sciences

52h-index30.0kcitations192works7.22yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Immunotherapy and Immune Responses(114), CAR-T cell therapy research(110), Cancer Immunotherapy and Biomarkers(76), Virus-based gene therapy research(33), T-cell and B-cell Immunology(15)

Publications190 total

598 Phase 2 trial of TIL therapy for metastatic uveal melanoma: evaluating cellular potency and tumor transcriptomic predictors of response
Regular and Young Investigator Award Abstracts·2025Open Access
370 Liver metastasectomy to obtain tumor-infiltrating lymphocytes: technical considerations and report on single center experience
Regular and Young Investigator Award Abstracts·2025Open Access
The lncRNA EPIC1 suppresses dsRNA-induced type I IFN signaling and is a therapeutic target to enhance TNBC response to PD-1 inhibition
Science Signaling·2025
The T cell receptor landscape of childhood brain tumors
Science Translational Medicine·2025· 6 cited
Optimizing TIL therapy for uveal melanoma: lessons learned and unlearned from cutaneous melanoma
Immunotherapy·2025· 5 citedOpen Access
Uveal melanoma immunogenomics predict immunotherapy resistance and susceptibility
Nature Communications·2024· 32 citedOpen Access
Supplementary Figure 1, Supplementary Figure 2 from Identification of an Immunogenic Subset of Metastatic Uveal Melanoma
2023Open Access
Data from Durable Complete Responses in Heavily Pretreated Patients with Metastatic Melanoma Using T-Cell Transfer Immunotherapy
2023Open Access
Data from CTLA-4 Blockade with Ipilimumab: Long-term Follow-up of 177 Patients with Metastatic Melanoma
2023Open Access
Data from CTLA-4 Blockade with Ipilimumab: Long-term Follow-up of 177 Patients with Metastatic Melanoma
2023Open Access
Supplemental figure 4 from Tumor-Infiltrating Lymphocytes Genetically Engineered with an Inducible Gene Encoding Interleukin-12 for the Immunotherapy of Metastatic Melanoma
2023Open Access
Supplementary Table 2 from Human Melanoma Metastases Demonstrate Nonstochastic Site-Specific Antigen Heterogeneity That Correlates with T-cell Infiltration
2023Open Access
Supplemental figure 4 from Tumor-Infiltrating Lymphocytes Genetically Engineered with an Inducible Gene Encoding Interleukin-12 for the Immunotherapy of Metastatic Melanoma
2023Open Access
Supplementary Data from A Phase II Study of Tumor-infiltrating Lymphocyte Therapy for Human Papillomavirus–associated Epithelial Cancers
2023Open Access
Data from A Phase II Study of Tumor-infiltrating Lymphocyte Therapy for Human Papillomavirus–associated Epithelial Cancers
2023Open Access
Supplementary Figure 1 from Persistence of CTL Clones Targeting Melanocyte Differentiation Antigens Was Insufficient to Mediate Significant Melanoma Regression in Humans
2023Open Access
Supplemental figure 5 from Tumor-Infiltrating Lymphocytes Genetically Engineered with an Inducible Gene Encoding Interleukin-12 for the Immunotherapy of Metastatic Melanoma
2023Open Access
Supplementary Figure 1, Supplementary Figure 2 from Identification of an Immunogenic Subset of Metastatic Uveal Melanoma
2023Open Access
Data from Persistence of CTL Clones Targeting Melanocyte Differentiation Antigens Was Insufficient to Mediate Significant Melanoma Regression in Humans
2023Open Access
Supplementary Data from Durable Complete Responses in Heavily Pretreated Patients with Metastatic Melanoma Using T-Cell Transfer Immunotherapy
2023Open Access
page 1 of 10Next →

Frequent Co-authors

Steven A. Rosenberg(41), Richard M. Sherry(31), Marybeth S. Hughes(23), James Chih‐Hsin Yang(20), Nicholas P. Restifo(19), Mark E. Dudley(16), Richard E. Royal(16), John R. Wunderlich(14), Donald E. White(13), Giao Q. Phan(11), Seth M. Steinberg(11), James C. Yang(11), Suzanne L. Topalian(10), Catherine Lévy(10), Carolyn M. Laurençot(9), Steven A. Feldman(8), Sharon Mavroukakis(7), Paul F. Robbins(7), Francesco M. Marincola(7), Robert Somerville(6)